An algorithm for the design of epidemiologic studies applied to drug surveillance

European Journal of Clinical Pharmacology

Volumn 51, Issue 6, 1997, Pages 445-448

  Figueiras, A ^a   Tato, F ^a   Takkouche, B ^a   Gestal Otero, J J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Adverse drug reactions; Algorithm; Case control studies; Cohort studies; Drug surveillance; Epidemiologic methods

Indexed keywords

ADVERSE DRUG REACTION; ALGORITHM; CASE CONTROL STUDY; COHORT ANALYSIS; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE; SHORT SURVEY;

ALGORITHMS; CASE-CONTROL STUDIES; COHORT STUDIES; EPIDEMIOLOGIC METHODS; HUMANS; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; RISK;

EID: 0030876756     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050228     Document Type: Short Survey

References (20)

1. Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research. Principles and quantitative methods. Van Nostrand Reinhold. New York, 78-81
2. Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D (1989) Mortality among oral contraceptive users: 20 year follow up of women in a cohort study. BMJ 299: 1487-1491
3. Bixler EO, Kales A, Manfredi RL, Vgontzas AN, Tyson KL, Kales JD (1991) Next-day memory impairment with triazolam use. Lancet 337: 827-831
4. DeWood MA, Wolbach RA (1990) Randomized double-blind comparison of side effects of nicardipine and nifedipine in angina pectoris. Am Heart J 119: 468-478
5. Katz M, Kroll D, Pak I, Osimoni A, Hirsch M (1985) Puerperal hypertension, stroke, and seizures after suppression of lactation whith bromocriptine. Obstet Gynecol 66: 822-824
6. Karch FE, Lasagna L (1977) Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 21: 247-254
7. Kelly JP, Auquier A, Rzany B, Naldi L, Bastuji-Garin S, Correia O, Shapiro S, Kaufman DW (1995) An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 1995; 48: 1099-1108
8. Maclure M (1991) The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 133: 144-153
9. Willich SN, Maclure M, Mittleman M, Arntz HR, Muller JE (1993) Sudden cardiac death. Support for a role of triggering in causation. Circulation 87: 1442-1450
10. Hebst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878-881
11. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist S, Rebuck AS (1992) The use of beta-agonists and the risk of death from asthma. N Engl J Med 326: 501-506
12. Suissa S (1995) The case-time-control design. Epidemiology 6: 248-253
13. Lipnick RJ, Buring JE, Hennekens CH, Rosner B, Willett W, Bain C, Stampfer MJ, Colditz GA, Peto R, Speizer FE (1986) Oral contraceptives and breast cancer: prospective cohort study. JAMA 255: 58-61
14. Persson I, Adami HO, Bergkvist L, Lindgren A, Pettersson B, Hoover R, Schairer C (1989) Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ 298: 147-151
15. Shapiro S (1989) The role of automated record linkage for postmarketing surveillance of drug safety: a critique. Clin Pharmacol Ther 46: 371-386
16. Schmidt LG, Grohmann R, Muller-Oerlinghausen B, Ochsenfahrt H, Schonhofer PS (1986) Adverse drug reactions to first- and second-generation antidepressants: a critical evaluation of drug surveillance data. Br J Psychiatry 148: 38-43
17. Chilvers CE, Deacon JM (1990) Oral contraceptives and breast cancer. Br J Cancer 61: 1-4
18. UK National Case-Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet i: 973-982
19. Sattin RW, Rubin GL, Wingo PA, Webster LA, Ory HW (1986) Oral contraceptive use and the risk of breast cancer. N Engl J Med 315: 405-411
20. Figueras A, Morales-Olivas FJ, Capell BD, Palop V, Laporte JR (1992) Bovine gangliosides and acute motor poly-neuropathy. BMJ 305: 1330-1331